The Evidence: MSCs vs. MUSE Cells
The difference in research depth is staggering.
MSCs have been studied for more than 50 years , with over 80,000 scientific publications and more than 1,500 clinical trials worldwide. Tens of thousands of patients have already received MSC treatments safely across multiple indications, from arthritis and orthopedic repair to autoimmune disorders and anti-aging.
MUSE cells, by comparison, were only identified in 2010. Fewer than 600 scientific papers exist on them, and fewer than 10 small clinical trials have been conducted, mostly in Japan. In total, fewer than 200 patients worldwide have received MUSE cells in a research context, and none of these trials have focused on musculoskeletal repair.
For patients, this means one thing: MSCs are among the most validated, trusted, and widely applied cell therapies in medicine. MUSE cells are still an interesting laboratory discovery.
Longevity Medical Institute (C) Copyright. All Rights Reserved.
07
Made with FlippingBook Digital Proposal Creator